Needham & Co downgrades OraSure (Nasdaq: OSUR) from Buy to Hold, saying FDA approval may be delayed for HIV ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE